Market Forecast By Applications (Cardiovascular, Neurology, Gastroenterology, Infectious Diseases, Oncology & Others), Regions(Germany, Italy, France, United Kingdom & Rest of Europe) and Competitive Landscape.
Product Code: ETC001177 | Publication Date: Sep 2021 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 200 | No. of Figures: 90 | No. of Tables: 30 | |
Europe Precision Medical Imaging Market developments include the collaboration of AMRA Medical with Pfizer aiming to generate the world’s largest imaging dataset on body composition profiling. In April 2019, Pfizer decided to work with Concerto HealthAI for a collaboration that will apply Concerto’s eurekaHealth artificial intelligence technology to precision oncology research. The partnership will aim to use the AI platform to gain faster actionable insights for Pfizer’s investigational therapies and commercialized therapeutics for the treatment of solid tumors and hematologic malignancies.
Report Name | Europe Precision Medical Imaging Market |
Forecast Period | 2025-2031 |
Market Size | USD 25 billion by 2031 |
CAGR | 7.5% |
Growing Sector | Healthcare |
The Europe Precision Medical Imaging Market report thoroughly covers the market by applications and key countries. The report provides an unbiased and detailed analysis of the ongoing market trends, opportunities/high-growth areas, and market drivers to help stakeholders align their strategies with current and future market dynamics.
The Europe Precision Medical Imaging Market is anticipated to increase significantly between 2025 and 2031, reaching a size of over USD 25 billion, with a CAGR of 7.5% by the end of the forecast period. The main factors that are driving this rise is the quick uptake of innovative imaging technologies including 3D imaging, molecular imaging, and AI-based diagnostics. The growth being driven by the rising incidence of chronic diseases like cancer, neurological disorders, and cardiovascular disease. With rise is preventative care and personalized medicine, with imaging being crucial to early detection and individualized treatment planning.
Technology is transforming the market and improving diagnostic accuracy and efficiency, especially in the areas of AI-powered imaging, molecular diagnostics, and 3D imaging systems. Leading nations like Germany, the United Kingdom, and France are at the forefront thanks to their robust healthcare systems and significant investments in R&D. However, the market is confronted with obstacles, including the expensive price of sophisticated machinery and complicated regulations, particularly in Eastern European nations. The move toward preventative healthcare and tailored medication is paving way for market expansion.
According to 6Wresearch, the Europe Precision Medical Imaging Market is anticipated to grow at a CAGR of 7.5% during the forecast period 2025-2031. The market is being driven by technological improvement such as 3D imaging, molecular imaging and AI-powered diagnostics, which enhance accuracy and efficiency. Rising number of chronic diseases, such as cancer, heart disease, and neurological disorders is another key driver. Government expenditure in healthcare projects in top nations like Germany, the UK and France is further accelerating the Europe Precision Medical Imaging Market growth. The focus on personalized medicine and preventive healthcare is also pushing innovative imaging solutions that provide early-stage detection and customized healthcare solutions.
However, the market faces some challenges such as expensive cost of sophisticated imaging equipment and associated infrastructure, particularly for the smaller healthcare providers and developing Eastern European markets. The licensing and adoption of modern medical imaging technology may be delayed by regulatory complications in many countries, which would hamper market expansion. Differences in healthcare access throughout the region, especially between Western and Eastern Europe, restrict the use of precision imaging technologies widely and have an impact on market adoption. Lack of knowledge and skills can also affect adoption of advance imaging devices.
Several key trends are shaping the growth trajectory of Europe Precision Medical imaging market. Diagnostic imaging is being revolutionized by emerging technologies like artificial intelligence (AI) and machine learning, which allow for greater accuracy, quicker processing, and predictive analytics. Imaging solutions are becoming more individualized to meet the demands of each patient. Remote diagnostics and telehealth integration are also becoming more popular since they improve access to imaging services in underdeveloped areas and streamline clinical procedures. Advances in 3D and 4D imaging, along with hybrid imaging methods like PET-CT, are also improving early disease monitoring and detection capacities.
The market presents many investment opportunities, especially in AI-driven imaging technologies that offer improved diagnostic efficiency and accuracy. Another promising area is the combination of telehealth and imaging technology, which can facilitate remote diagnostics and increase access in underprivileged areas like Eastern Europe. Interest in personalized medicine is growing, and precision imaging is essential to customizing health care for each patient. Developments in hybrid imaging systems, such PET-CT and PET-MRI, are also garnering attention. Furthermore, a thriving environment for innovation and market expansion is created by government funding programs in top markets like Germany and France.
Leading companies like Siemens Healthineers, GE Healthcare, and Philips Healthcare dominate the European precision medical imaging market and are fostering innovation in the industry. These businesses are making significant investments in AI integration to improve process efficiency and diagnostic accuracy. For example, GE Healthcare prioritizes hybrid imaging technologies like PET/MRI, while Siemens Healthineers concentrates on precision medicines and advanced imaging systems. Smart imaging solutions are being used by Philips Healthcare to enhance patient outcomes and provide more individualized treatment. Furthermore, new competitors are joining the market with specialized products, escalating rivalry and creating a dynamic, innovation-driven environment.
Government regulations that play important role are largely set by the European Medicines Agency (EMA) and frameworks such as the EU Medical Device Regulation (MDR). For example, the MDR has tightened requirements for medical device approval, placing a strong emphasis on thorough clinical testing and post-market monitoring. Greater safety and quality standards are guaranteed, but there are drawbacks as well, like greater compliance costs and longer certification periods, which might postpone the release of innovative technology in the market. Positively, these frameworks stimulate innovation by establishing a strong and open regulatory environment that promotes the production of high-precision imaging systems.
The Europe precision medical imaging industry appears to have a bright future as major developments in AI and machine learning are improving diagnostic precision and expedite procedures. It is anticipated that personalized medicine will become the main focus, with precision imaging being essential to the development of customized healthcare solutions. In underserved areas, the use of telehealth and remote diagnostics is also anticipated to grow quickly, filling in healthcare gaps and enhancing access. Innovation will be supported by investments from the public and private sectors, leading to the creation of innovative technologies such as hybrid imaging systems.
The report offers a comprehensive study of the following market segments and their leading categories
According to Ashutosh, Senior Research Analyst at 6Wresearch, oncology is predicted to dominate the market because cancer is becoming more common in Europe and precision imaging is essential for early identification, staging, and tracking treatment outcomes. Neurology is also expected to increase significantly as a result of improvements in neuroimaging for the diagnosis of neurological diseases.
Germany is anticipated to dominate the market share underpinned by its sophisticated healthcare system, high rate of uptake of innovative imaging technology, and substantial investment in medical innovation.
Europe Precision Medical Imaging market report covers a detailed analysis of the following market segments
1. Executive Summary |
2. Introduction |
2.1 Report Description |
2.2 Key Highlights of The Report |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3. Europe Precision Medical Imaging Market Overview |
3.1 Europe Country Indicators |
3.2 Europe Precision Medical Imaging Market Revenues and Volume 2021-2031F |
3.3 Europe Precision Medical Imaging Market Revenue Share, By Applications, 2021 & 2031F |
3.5 Europe Precision Medical Imaging Market Revenue Share, By Regions, 2021 & 2031F |
3.6 Europe Precision Medical Imaging Market - Industry Life Cycle |
3.7 Europe Precision Medical Imaging Market - Porter’s Five Forces |
4. Europe Precision Medical Imaging Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5. Europe Precision Medical Imaging Market Trends |
6. Europe Precision Medical Imaging Market Overview, By Applications |
6.1 Europe Precision Medical Imaging Market Revenues and Volume, By Cardiovascular, 2021-2031F |
6.2 Europe Precision Medical Imaging Market Revenues and Volume, By Neurology, 2021-2031F |
6.3 Europe Precision Medical Imaging Market Revenues and Volume, By Gastroenterology, 2021-2031F |
6.4 Europe Precision Medical Imaging Market Revenues and Volume, By Infectious diseases, 2021-2031F |
6.5 Europe Precision Medical Imaging Market Revenues and Volume, By Oncology, 2021-2031F |
6.6 Europe Precision Medical Imaging Market Revenues and Volume, By Others, 2021-2031F |
7 Germany Precision Medical Imaging Market Overview |
7.1 Germany Precision Medical Imaging Market Revenues & Volume, 2021-2031F |
7.2 Germany Precision Medical Imaging Market Revenues and Volume, By Applications, 2021-2031F |
8 France Precision Medical Imaging Market Overview |
8.1 France Precision Medical Imaging Market Revenues & Volume, 2021-2031F |
8.2 France Precision Medical Imaging Market Revenues and Volume, By Applications, 2021-2031F |
9 United Kingdom Precision Medical Imaging Market Overview |
9.1 United Kingdom Precision Medical Imaging Market Revenues & Volume, 2021-2031F |
9.2 United Kingdom Precision Medical Imaging Market Revenues and Volume, By Applications, 2021-2031F |
10 Italy Precision Medical Imaging Market Overview |
10.1 Italy Precision Medical Imaging Market Revenues & Volume, 2021-2031F |
10.2 Italy Precision Medical Imaging Market Revenues and Volume, By Applications, 2021-2031F |
11 Rest of Europe Precision Medical Imaging Market Overview |
11.1 Rest of Europe Precision Medical Imaging Market Revenues & Volume, 2021-2031F |
12 Europe Precision Medical Imaging Market - Key Performance Indicators |
13 Europe Precision Medical Imaging Market - Opportunity Assessment |
13.1 Europe Precision Medical Imaging Market Opportunity Assessment, By Applications, 2031F |
14 Europe Precision Medical Imaging Market Competitive Landscape |
14.1 Europe Precision Medical Imaging Market Revenue Share, By Companies, 2024 |
14.1.1 Germany Precision Medical Imaging Market Revenue Share, By Companies, 2024 |
14.1.2 United Kingdom Precision Medical Imaging Market Revenue Share, By Companies, 2024 |
14.1.3 Italy Precision Medical Imaging Market Revenue Share, By Companies, 2024 |
14.1.4 France Precision Medical Imaging Market Revenue Share, By Companies, 2024 |
14.2 2 Europe Precision Medical Imaging Market Competitive Benchmarking, By Operating & Technical Parameters |
15 Company Profiles |
16 Key Recommendations |
17 Disclaimer |